Squarepoint
BOLD

Squarepoint’s Audentes Therapeutics, Inc BOLD Stock Holding History

Squarepoint’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-105,053
Closed -$2.95M – 2966
2019
Q3 		$2.95M Buy
105,053
+53,053
+102% +$1.81M 0.03% 671
2019
Q2 		$1.97M Sell
52,000
-16,658
-24% -$640K 0.02% 854
2019
Q1 		$2.68M Buy
68,658
+27,796
+68% +$797K 0.03% 654
2018
Q4 		$871K Buy
40,862
+10,083
+33% +$260K 0.01% 981
2018
Q3 		$1.22M Buy
30,779
+12,679
+70% +$473K 0.01% 902
2018
Q2 		$692K Buy
18,100
+3,200
+21% +$119K 0.01% 1044
2018
Q1 		$448K Buy
14,900
+5,598
+60% +$190K 0.01% 1130
2017
Q4 		$291K Buy
+9,302
New +$255K 0.01% 1530

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Squarepoint's BOLD Position: Q4 2019 in Review

Squarepoint sold out of Audentes Therapeutics, Inc (BOLD) in Q4 2019, closing a stake of 105,053 shares — an estimated $2.95M sold.

Squarepoint first reported a position in BOLD in Q4 2017 and held it in 8 quarters. The position peaked at $2.95M in Q3 2019. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • Squarepoint reported no remaining Audentes Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • Squarepoint sold 105,053 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $2.95M.
  • Squarepoint first reported a position in Audentes Therapeutics, Inc in Q4 2017 and held it in 8 quarters.
  • Squarepoint's Audentes Therapeutics, Inc position peaked at $2.95M in Q3 2019.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on Squarepoint's 13F filing for Q4 2019, filed 14 Feb 2020.